- Home
- >
- Services
- >
- Diagnostics
- >
- Cancer panel
CancerInside is an examination that can screen for the likelihood of developing familial cancer. Theragen Bio analyzes 31 genetic variations that can cause familial cancer using its own NGS technology. This examination conducted as a preventive measure for the early detection of cancer with the prediction of cancer incidence risk. It also increases treatment effects, minimizes side effects, and saves costs with targeted anticancer prescriptions and customized treatments that consider genetic differences.
Examination Items
Breast cancer, Colorectal cancer, Kidney cancer, Melanoma, Ovarian cancer, Pancreatic cancer, Uterine cancer), Multiple cancer (Le-Fraumeni syndrome, Peutz-Jeghers syndrome, Von Hippel-Lindau sydrome, ynch syndrome etc.
Examination Procedure
01
Sample Receiving
02
DNA extraction
03
Production of sequencing library
04
Gene sequence analysis
05
Sequencing data analysis
06
Confirmation of sequencing mutations
07
Result report
Analysis Items
Causal mutation analysis
Analysis equipment
Next Generation Sequencing(NGS) Systems
Sample Conditions
Tissue or DNA
BRCAInside is an examination of genetic variation of BRCA1 and BRCA2. This examination is only done when doctors recommend it for the families of breast and ovarian cancer patients. This examination can also be used for the prediction of incidence risk, early detection of cancer, and prescription and treatment with customized anticancer drugs.
Examination Items
Breast cancer, Ovarian cancer
Examination Procedure
01
Sample Receiving
02
DNA extraction
03
Production of sequencing library
04
Gene sequence analysis
05
Sequencing data analysis
06
Confirmation of sequencing mutations
07
Result report
Analysis Items
Causal mutation analysis
Analysis equipment
Next Generation Sequencing(NGS) Systems
Sample Conditions
Blood or DNA
This is a test that analyzes the causes of cancer and provides important information for personalized cancer treatment by analyzing variations in major genes related to cancer incidence using NGS technology, unlike the existing single gene variation test. It helps to determine treatment methods such as the prescription of targeted anticancer drugs, and unlike the single gene variation test, various somatic cancer-related genes can be examined at once.
Examination Items
Somatic cancer includes ones that affect Koreans more, such as lung cancer, colon cancer, and gastric cancer
Examination Procedure
01
Sample Receiving
02
DNA extraction
03
Production of sequencing library
04
Gene sequence analysis
05
Sequencing data analysis
06
Confirmation of sequencing mutations
07
Result report
Analysis Items
Causal mutation analysis
Analysis equipment
Next Generation Sequencing(NGS) Systems
Sample Conditions
Tissue or DNA
* This service is commercially available for the clinical research of medical staff as well as people who have a family history of cancer, and services in hospitals are possible according to the recommendation of doctors.
